Gene S Tan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Pregnancy Outcomes

Inflammatory Response

Coronavirus Disease

Top Venues

Science translational medicine

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Chung-Young Lee, Vedhika Raghunathan, Carlos Joaquin Caceres, Ginger Geiger, Brittany Seibert, Flavio Cargnin Faccin, L Claire Gay, Lucas M Ferreri, Drishti Kaul, Jens Wrammert, Gene S Tan, Daniel R Pérez, Anice C Lowen
Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies. Proceedings of the National Academy of Sciences of the United States of America 120 (17) (2023)
Saborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, Venkata Vamsee Aditya Mallajosyula, Srijoni Chakraborty, Megha Dubey, Usama Ashraf, Bowie Yik-Ling Cheng, Nimish Kathale, Kim Quyen Thi Tran, Courtney Scallan, Aanika Sinnott, Arianna Cassidy, Steven T Chen, Terri Gelbart, Fei Gao, Yarden Golan, Xuhuai Ji, Seunghee Kim-Schulze, Mary K Prahl, Stephanie L Gaw, Sacha Gnjatic, Thomas U Marron, Miriam Merad, Prabhu S Arunachalam, Scott D Boyd, Mark M Davis, Marisa K Holubar, Chaitan Khosla, Holden Terry Maecker, Yvonne Maldonado, Elizabeth D Mellins, Kari Christine Nadeau, Bali Pulendran, Upinder Singh, Aruna K Subramanian, Paul J Utz, Robert Sherwood, Sheng Zhang, Prasanna Jagannathan, Gene S Tan, Taia T Wang
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science translational medicine 14 (635) (2022)
Benjamin L Sievers, Saborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C Gonzalez, Arianna G Cassidy, Yarden Golan, Mary K Prahl, Stephanie L Gaw, Prabhu S Arunachalam, Catherine A Blish, Scott D Boyd, Mark M Davis, Prasanna Jagannathan, Kari Christine Nadeau, Bali Pulendran, Upinder Singh, Richard H Scheuermann, Matthew B Friemann, Sanjay Vashee, Taia T Wang, Gene S Tan
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Science translational medicine 14 (634) (2022)